In an adult male with total testosterone around 330 ng/dL, free testosterone about 32 pg/mL, follicle‑stimulating hormone (FSH) ~15 IU/L, and luteinizing hormone (LH) ~12.7 IU/L, what is the likely diagnosis and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Hypogonadism (Hypergonadotropic Hypogonadism)

This patient has primary hypogonadism, characterized by testicular failure with elevated gonadotropins (FSH 15 IU/L, LH 12.7 IU/L) attempting to compensate for low-normal testosterone production (total testosterone 330 ng/dL, free testosterone 32 pg/mL). 1, 2

Diagnostic Interpretation

The hormonal pattern is diagnostic:

  • Total testosterone 330 ng/dL: Borderline low (most guidelines use <264-300 ng/dL as diagnostic threshold) 2, 3
  • Free testosterone 32 pg/mL: Low (typically <63 pg/mL indicates hypogonadism) 4
  • FSH 15 IU/L and LH 12.7 IU/L: Both elevated, indicating the pituitary is appropriately responding to testicular insufficiency by increasing gonadotropin output 1, 2

This elevated gonadotropin pattern with low/low-normal testosterone definitively establishes primary (hypergonadotropic) hypogonadism — the testes are failing despite maximal pituitary stimulation 1, 2, 3. In contrast, secondary hypogonadism would show low or inappropriately normal gonadotropins 2, 3.

Critical Next Steps

1. Identify the Underlying Cause

You must investigate the etiology of testicular dysfunction 1, 2:

  • Klinefelter syndrome (most common cause, affects 2 in 1000 men, frequently undiagnosed): Order karyotype 3
  • Prior chemotherapy or radiation to testes
  • Bilateral orchitis (mumps, trauma)
  • Cryptorchidism history
  • Testicular torsion or surgery
  • Medications/toxins: Check for drugs interfering with testosterone production 1
  • Systemic diseases: HIV, sickle cell disease, myotonic dystrophy 1

2. Assess Symptoms and Comorbidities

Document specific hypogonadal symptoms 1, 2:

  • Decreased libido
  • Erectile dysfunction (specifically decreased spontaneous erections)
  • Reduced testicular volume on examination
  • Gynecomastia
  • Decreased muscle mass/strength
  • Fatigue
  • Infertility concerns

Evaluate metabolic factors that may worsen the condition 1:

  • BMI and waist circumference (obesity can compound hypogonadism)
  • Screen for metabolic syndrome/type 2 diabetes
  • Check hematocrit baseline

3. Confirm Free Testosterone is Truly Low

Free testosterone assessment is critical here 5, 4. With borderline total testosterone (330 ng/dL), calculated free testosterone provides more accurate diagnosis, especially if the patient has obesity, diabetes, or conditions affecting SHBG 3, 4. The free testosterone of 32 pg/mL is definitively low and correlates better with clinical symptoms than total testosterone 4.

Management Algorithm

Testosterone Replacement Therapy is Indicated 1, 2

Primary hypogonadism cannot be reversed — the testes are permanently damaged 1. Unlike secondary hypogonadism where treating underlying causes (obesity, medications) may restore function, primary hypogonadism requires lifelong testosterone therapy 1, 3.

Before initiating therapy, screen for contraindications 2:

  • Planning fertility in near term (testosterone suppresses spermatogenesis further)
  • Prostate cancer or PSA >4 ng/mL (>3 ng/mL in high-risk men)
  • Elevated hematocrit
  • Untreated severe obstructive sleep apnea
  • Severe lower urinary tract symptoms
  • Uncontrolled heart failure
  • MI or stroke within 6 months
  • Thrombophilia

Testosterone Formulation Selection 2

Choose based on patient preference, cost, and convenience:

  • Intramuscular injections (testosterone enanthate/cypionate 200 mg every 2 weeks)
  • Transdermal gels (daily application)
  • Oral formulations (newer options)

Target mid-normal testosterone range during treatment 2. Aim for total testosterone 450-600 ng/dL.

Monitoring Protocol 2

First year after initiation:

  • Symptoms and adverse effects at each visit
  • Serum testosterone levels (timing depends on formulation)
  • Hematocrit (testosterone increases red blood cell production)
  • PSA in men >40 years
  • Compliance assessment

Critical Pitfalls to Avoid

  1. Do not assume lifestyle modification alone will help: Unlike functional/secondary hypogonadism from obesity where weight loss can normalize testosterone 1, 3, primary hypogonadism reflects irreversible testicular damage requiring testosterone replacement 1.

  2. Do not miss Klinefelter syndrome: This is the most common cause of primary hypogonadism and frequently goes undiagnosed 3. Order karyotype.

  3. Counsel about fertility: Testosterone therapy will further suppress spermatogenesis 2. If fertility is desired, refer to reproductive endocrinology for sperm banking before starting therapy or consider alternative approaches (though options are limited in primary hypogonadism).

  4. Do not rely solely on total testosterone: The free testosterone of 32 pg/mL provides stronger evidence of true androgen deficiency than the borderline total testosterone 5, 4. The elevated gonadotropins independently confirm testicular insufficiency even when total testosterone appears "acceptable" 5.

Related Questions

What is the diagnosis for a 55‑year‑old male with consistently low total and free testosterone, normal SHBG, low‑normal FSH and LH, and normal prolactin levels?
In a male patient with a free testosterone of 2.7 pg/mL and a total testosterone of 392 ng/dL, what does this indicate and what are the recommended next steps?
In a 41-year-old man with primary hypogonadism, low SHBG, elevated FSH and LH, normal prolactin, low estradiol, and low testosterone despite daily testosterone gel (Androgel), what workup and treatment are recommended?
In a 66‑year‑old man with an isolated elevated follicle‑stimulating hormone (FSH) and normal luteinizing hormone (LH), total and free testosterone, and sex hormone‑binding globulin (SHBG), can testosterone replacement therapy be the cause?
When is free testosterone measurement preferred over total testosterone for diagnosing male hypogonadism?
In a 47-year-old male with obesity (BMI 30) and persistent hypertension (BP ~152/98), no major comorbidities except a gout flare two years ago treated with indomethacin, what is the ranked differential diagnosis for his elevated blood pressure with rationale, and how should his gout history influence the selection of first-line antihypertensive therapy?
How should I taper a patient who is taking lorazepam 0.25 mg daily?
For a 47-year-old man with hypertension and gout, can the VINDICATE (Vascular, Infectious, Neoplastic, Degenerative, Iatrogenic, Congenital, Autoimmune, Traumatic, Endocrine) framework be used for his initial assessment and differential diagnosis?
What dose does one quarter of a 0.5 mg tablet represent?
What are the typical physical features of Down syndrome in a term newborn?
Is testosterone replacement therapy appropriate for a patient with diabetes and hyperlipidemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.